Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Peptide Antisense Nanoparticles

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Gene Regulation with Polyvalent siRNA-Nanoparticle Conjugates*

One-pot Synthesis of Functional Peptide-Modified Gold Nanoparticles for Gene Delivery

Biocompatible Infinite‐Coordination‐Polymer Nanoparticle–Nucleic‐Acid Conjugates for Antisense Gene Regulation

Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides

Gold Nanoparticles Functionalized with Therapeutic and Targeted Peptides for Cancer Treatment

Precision Tuning of DNA- and Poly(ethylene Glycol)-Based Nanoparticles Via Coassembly for Effective Antisense Gene Regulation

Modular Construction of Multifunctional Bioresponsive Cell-Targeted Nanoparticles for Gene Delivery.

A nanoparticle for tumor targeted delivery of oligomers.

Multiple Thiol-Anchor Capped DNA-gold Nanoparticle Conjugates.

Conjugation of Peptides to Gold Nanoparticles

Polyvalent nucleic acid nanostructures.

Endosomolytic Peptides Enable the Cellular Delivery of Peptide Nucleic Acids

Gene Regulation with Polyvalent Sirna-Nanoparticle Conjugates.

Multifunctional, Self-Assembling Anionic Peptide-Lipid Nanocomplexes for Targeted Sirna Delivery.

Multifunctional gold nanoparticle-peptide complexes for nuclear targeting.

A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides

Rational Design of Functional Peptide–Gold Hybrid Nanomaterials for Molecular Interactions

Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation